Breaking
June 5, 2026

Health

MGM Healthcare Achieves India’s First LVAD Heart Pump Implant in Nearly 80-Year-Old Heart Failure Patient

Chennai, May 21, 2026: Setting a first-of-its-kind milestone in cardiac care in India, MGM Healthcare has successfully implanted a Left Ventricular Assist Device (LVAD), a mechanical heart pump, in a nearly 80-year-old retired Chennai resident suffering from advanced heart failure and co-morbidities including low blood pressure, worsening kidney function, and lung congestion.

The patient’s heart had become too weak to pump enough blood to the rest of the body, the vital function performed by the left ventricle. This condition is known as left ventricular failure, or advanced left ventricular systolic heart failure. As a result, he frequently suffered severe breathlessness and required repeated ICU admissions. On one occasion, he had to be readmitted to the ICU on the very same day he was discharged from the hospital. Seeking a permanent solution to his recurring breathlessness and the underlying heart condition, the patient opted for advanced definitive treatment.

Considering his advanced age, fragile clinical condition and worsening kidney function, the medical team ruled out heart transplantation and instead opted for implantation of a LVAD. The device sits inside the left ventricle and takes over much of the pumping function.

The LVAD implantation was performed by the team lead Dr. K R Balakrishnan, Chairman- Cardiac Sciences, Director- Institute of Heart and Lung Transplant & mechanical Circulatory Support and Dr. Suresh Rao K G, Co- Director- Institute of Heart and Lung Transplant & mechanical Circulatory Support at MGM Healthcare. The intervention was successful, following which the patient recovered in hospital for three weeks before being discharged. He is now living independently, able to go for regular walks and leading an active, brisk life.

In his comments, Dr. K R Balakrishnan said, “Our heart works as a two-sided pump, the right side sends blood to the lungs, while the left side pumps blood to the rest of the body. In this patient, the left side had become extremely weak and was barely able to perform its function, which is why he was experiencing frequent breathlessness and repeated hospitalisations. A conventional heart transplant was not feasible because of his advanced age, fragile condition and worsening kidney function. Even LVAD implantation carried significant risk, as multiple organs were beginning to fail. We therefore carried out a comprehensive evaluation, including heart function studies, lung pressure assessment, and checks of all major organs from the kidneys to the brain. Although LVAD is usually an elective procedure, in his case there was little time to wait as his organs were deteriorating, making timely intervention critical. We are extremely happy that the procedure went well.”

In his comments, Dr. Suresh Rao said, “LVAD technology was originally introduced as a bridge-to-transplant option for very sick patients awaiting a donor heart. Today, it is also being used selectively as a long-term therapy for patients who may not undergo transplantation. While the hospital has implanted LVADs in many patients below 65 years of age, this is the first time it has performed the procedure in a patient close to 80 years old.

In his comments Mr. Nilesh Mundada, COO, MGM Healthcare & Sr. VP – Finance, MGM Group, said, “MGM Healthcare’s commitment has reflected the milestone of pushing past the boundaries of advanced cardiac care as well as bringing in life-saving innovations to patients. The successful implanting of LVAD in a nearly 80-year-old patient, who had an advanced heart failure, emphasizes the strength of our experts. As heart failure continues to emerge as a growing health challenge, we will remain committed to delivering world-class treatment solutions that help us improve the outcomes and give patients renewed hope and quality of life.

India’s First Right Shoulder-Artery Heart Valve Replacement Performed at SRM Prime Hospital

Chennai, April 2 2026: In a first in India, SRM Prime Hospital performed an Alternate Access Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI), a minimally invasive heart valve replacement procedure, through the artery under the right shoulder (right axillary artery), instead of the standard leg artery route, to save a 73-year-old patient with calcific severe aortic stenosis, a condition in which the heart valve narrows due to calcium deposits, restricting blood flow from the heart to the body.

The patient, a retired professional, was discharged the third day after the procedure, and is now able to resume normal daily activities as before.

TAVR/TAVI procedure is used to replace a diseased aortic valve without the need for open-heart surgery. Doctors deliver an artificial valve through a thin tube inserted into a blood vessel (artery) and position it within the narrowed valve to restore normal blood flow. The most common route is through the artery in the leg. However, in this patient, all conventional access routes proved to be unsuitable due to vascular limitations such as narrowing, blockages, or unfavorable anatomy of the blood vessels. As a result, doctors opted for the right axillary artery.

The Procedure was led by Dr. Balamurugan S, Consultant – Interventional Cardiology and supported by Dr. A. Thomas George, Senior Consultant – Internal Medicine & Diabetology, Dr. P Balasubramanian, Senior Consultant – Cardiothoracic and Vascular Surgery, Dr. A. B. Gopalamurugan, Procedure Proctor, Cardiac Anesthetists and Critical Care Intensivist.

In his comments Dr. Balamurugan, said, “The patient exhibited features of decompensated heart failure, where the heart is unable to pump effectively. Our evaluation confirmed calcific severe aortic stenosis, a narrowing of the aortic valve caused by calcium deposits that restrict blood flow. Given his age and condition, we opted for TAVR/TAVI; however, none of the standard access routes such as femoral, transcarotid, transcaval or Left subclavian, were feasible. The only viable option was the right axillary artery. We therefore performed this entirely percutaneous right trans-axillary TAVR, an India-first, using an advanced catheter-based valve delivery system.”

He further added, “Modern treatments like TAVR provide safe and minimally invasive options, as there is less surgical trauma and faster recovery options, especially for elderly patients or those at high risk for open-heart surgery. In this case, it required advanced pre-procedure planning and precise catheter manipulation due to the tortuous course of the artery, along with expertise in alternative vascular access techniques. We are happy that our team, with utmost dedication to the quality outcome, performed the first of the kind procedure in India, and saved the senior citizen’s life.”

In his comments Dr. A. Thomas George said, “Patients undergoing advanced procedures like TAVR are often elderly and have multiple underlying health conditions that need careful medical management. Our focus is on optimising these conditions and ensuring the patient remains stable throughout the treatment journey.”

Aortic stenosis is primarily a disease of the elderly, with an incidence of about 2-7% in people above 65 years. It is usually caused by age-related valve degeneration and can also occur in conditions like chronic kidney disease. While age-related degeneration cannot always be prevented, risk can be reduced by controlling blood pressure and managing cholesterol. Regular cardiac check-ups, especially after age 60, is important.

People should not ignore early warning signs such as fatigue during mild exertion, breathlessness, chest discomfort, and fainting spells. These symptoms may indicate serious valve disease. Early diagnosis allows timely treatment and helps prevent complications such as heart failure and sudden cardiac death.

MGM Healthcare Malar, Adyar Removes Congenital Lung Defect in One-Year-Old Using Minimally Invasive Surgery

Chennai, March 17 2026: MGM Healthcare Malar, Adyar has successfully performed a Video-Assisted Thoracoscopic Surgery (VATS), a minimally invasive procedure, on a one-year-old girl to remove a congenitally developed non-functional portion of the lung (the lower lobe of the left lung) which posed a potential risk of severe respiratory complications, recurrent infections, or bleeding in the future, and could also have adversely affected heart function.

The condition, known as bronchopulmonary sequestration – a congenital malformation of the airway and lung – was diagnosed during fetal development and closely monitored until the child turned one year old, allowing doctors to plan the surgery safely for optimal outcomes. The condition is rare, accounting for only about 2% of congenital lung anomalies. The successful use of VATS to treat bronchopulmonary sequestration marks a first-of-its-kind achievement in Chennai.

The procedure was performed by Dr. Karpaga Vinayagam, Senior Consultant – Paediatric Surgery, who led a team including Dr. Mohan Raj, Consultant – Paediatric Surgery; Dr. Prabhakaran G, Senior Consultant, Paediatrics; Dr.Arun Kumar S, Lead Consultant – Neonatology, Dr. N.K.V. Vigneshwar, Associate Consultant – Neonatology, Dr. Vidhya Mohanram, Senior Consultant, Anaesthesia; and the multidisciplinary ICU team.

The procedure lasted approximately three and a half hours. During surgery, the team carefully removed the affected lower lobe of the left lung and ligated the abnormal blood supply from the aorta to the diseased segment.

In his comments, Dr. Karpaga Vinayagam said, “This was a particularly challenging surgery because the bronchopulmonary sequestration was located entirely within the left lung lobe and had a major blood supply directly from the aorta. Performing the procedure thoracoscopically in a child is technically demanding due to the limited space in the chest cavity. However, we opted for it, as this minimally invasive approach could mean less post-operative pain, a shorter hospital stay, and faster recovery compared to conventional open surgery.”

The child’s recovery has been remarkable. She was monitored in the ICU, shifted to the ward after two hours, and discharged within three days. Paediatric lungs continue to grow until around nine years of age, allowing the remaining lung to compensate for the removed lower lobe. She is expected to lead a normal, healthy life.

In his comments, Mr. Venugopal Bhat, Chief Operating Officer and Vice President – Group Strategic Initiatives, MGM Healthcare Malar, Adyar, said, “This successful surgery demonstrates our commitment to advanced paediatric surgical care and highlights our focus on minimally invasive techniques that ensure faster recovery and better outcomes for our patients.”

Kauvery Hospitals Highlights Importance of Early Access to Level I Trauma Care on World Head Injury Awareness Day

Chennai, March 17, 2026: Marking World Head Injury Awareness Day (March 20), the Kauvery Group of Hospitals emphasised the critical importance of rapid access to Level I Trauma Care Centres for patients suffering from severe head injuries and other life-threatening trauma. Thiru K Shankar, IPS, Director General of Prisons and Correctional Services, graced the occasion.

Head injury refers to trauma affecting the scalp, skull or brain, most commonly caused by road traffic accidents, falls, sports injuries or assaults. Globally, more than 50 million people sustain head injuries each year, while in India the estimated incidence is around 1.5 million annually, with nearly 60% resulting from road traffic accidents.

Trauma care facilities are categorised into four levels depending on the expertise and infrastructure available. Level I Trauma Care Centres represent the highest level of emergency care, equipped to manage the most complex and severe injuries.

Addressing the media, Dr Krish Sridhar, Group Mentor – Neurosciences and Director, Institute of Brain & Spine, Kauvery Hospital, Radial Road, said that timely and specialised trauma care plays a decisive role in saving lives. “Head injury is one of the most serious consequences of trauma, particularly in road traffic accidents. The outcome for the patient depends greatly on how quickly they reach a Level I Trauma Care Centre where specialised teams and advanced facilities are available round-the-clock. Early access to such centres during the golden hour can significantly improve survival and neurological recovery,” he noted.

In his comments, Dr Ranganathan Jothi, Chief – Brain & Spine Surgeon and Director of Neurosciences, Kauvery Hospital Vadapalani, said, “Many serious head injuries require urgent neurosurgical intervention. In patients with traumatic brain injury, conditions such as intracranial bleeding or brain swelling can deteriorate rapidly if not treated promptly. Immediate access to neurosurgical expertise, advanced imaging and intensive care – all available in a Level I Trauma Care Centre – can make the difference between life and death or between full recovery and long-term disability.”

Dr Aravindan Selvaraj, Co-Founder and Executive Director, Kauvery Group of Hospitals, commented: “World Head Injury Awareness Day is an important reminder of the growing burden of trauma in our society. Strengthening trauma systems and ensuring that patients are transported quickly to advanced trauma centres is critical. Across the Kauvery network, our trauma teams are equipped to provide comprehensive emergency care so that patients receive timely treatment during the most critical moments.”

Kauvery Hospitals manages hundreds of trauma and head injury cases every year, particularly across its advanced facilities in Chennai, including Alwarpet, Radial Road and Vadapalani, where specialised neurosurgical and trauma teams function round-the-clock.

Across the Kauvery network, Level I Trauma Care Centres are equipped with: 24×7 availability of neurosurgeons, trauma surgeons, emergency physicians and critical care specialists; advanced imaging facilities, including CT and MRI; dedicated trauma resuscitation teams; immediate access to operating theatres for emergency surgery; specialised neuro-critical care and intensive care units, and multidisciplinary teams capable of managing complex polytrauma cases.

To further support emergency response, Kauvery Hospital has strengthened its advanced ambulance network and introduced an SOS feature in the Kauvery Kare mobile application, enabling users to quickly request emergency assistance and ambulance transport to the nearest trauma care facility. Through continued awareness initiatives and advanced trauma care systems, Kauvery aims to improve survival and reduce long-term disability among patients with severe head injuries.

10th Edition of CAHOCON 2026 to Bring 2,500 Healthcare Leaders to Chennai to Advance Patient Safety

Chennai, 12 March, 2026: The 10th edition of CAHOCON 2026, India’s premier healthcare quality conference organised by the Consortium of Accredited Healthcare Organizations (CAHO), will be held from April 10 to 12, 2026, in Chennai, bringing together 2,500 healthcare leaders, clinicians, administrators, and policymakers – including over 200 international delegates, to discuss advancements in patient safety, healthcare quality, accreditation, and digital transformation.

Guided by the theme ‘Tech. Touch. Trust – The New Healthcare Code’, CAHOCON 2026 will emphasise the human connection, reliability, and innovation at the heart of advancing healthcare quality and patient safety. The main conference will feature high-impact scientific sessions, panel discussions, innovation showcases, and interactive networking opportunities, along with poster presentations by researchers and clinicians that highlight innovative projects and foster knowledge exchange.

Alongside the conference, CAHOCON 2026 will host a comprehensive healthcare exhibition with around 150 stalls, showcasing cutting-edge products and services from leading medical equipment manufacturers, digital health companies, pharmaceutical firms, and service providers. The conference will also feature three breakout houses, designed to facilitate smaller group discussions, interactive workshops, and focused learning sessions.

Recognised by the International Society for Quality in Healthcare (ISQua) as the first ISQua Regional Conference for South Asia, CAHOCON 2026 will witness addresses by 20 ISQua experts. The conference will honour excellence in healthcare quality and patient safety through the prestigious CAHO Awards, celebrating institutions and professionals who have made outstanding contributions to advancing healthcare standards.

The pre-conference workshops on April 10 will bring together 32 leading hospitals from Chennai, providing hands-on training and practical insights into quality improvement and patient safety.

Addressing a press meet, Dr. Vijay Agarwal, President, CAHO, said, “Over the past decade, CAHO has evolved into a powerful national movement dedicated to strengthening healthcare quality and patient safety across India. Through continuous training, accreditation support, knowledge-sharing platforms and collaborative initiatives, we are working to build a culture where quality and safety are embedded in every aspect of healthcare delivery.

Dr. Lallu Joseph, Secretary General, CAHO, and AGS & Quality Manager at Christian Medical College, Vellore, commented: “CAHOCON has grown into one of the most influential platforms for advancing healthcare quality and patient safety in India. It brings together clinicians, hospital administrators, quality professionals and policymakers to exchange ideas, share best practices and learn from global experiences. Through this collaborative forum, we aim to strengthen a culture of continuous improvement in healthcare systems and ensure that patients across the country benefit from safer and higher-quality care.”

In his address, Dr. S. Manivannan, Org. Co-Chairperson, CAHOCON 2026 and Founder & Managing Director of Kauvery Group of Hospitals, said: “CAHOCON 2026 is set to be a landmark gathering for healthcare professionals from across the country, bringing together clinicians, administrators, researchers, and innovators under one roof. This year’s event will feature pre-conference workshops, high-impact scientific sessions, and panel discussions designed to address the latest advancements and challenges in healthcare. Our attendees will gain unparalleled opportunities for knowledge exchange, networking, and collaboration, while also exploring practical solutions that can be implemented in their institutions.”

Dr. Sathish Devadoss, Org. Secretary, CAHOCON 2026 and Vice Chairman of Devadoss Multispecialty Hospitals, Madurai, said: “CAHOCON 2026 will feature a dynamic array of scientific sessions, covering the latest breakthroughs, clinical practices, and emerging technologies in healthcare. Our pre-conference workshops are designed to offer hands-on learning experiences, equipping participants with practical skills and innovative approaches that can be applied immediately in their practice. From expert-led lectures to interactive panel discussions, the event promises to stimulate meaningful dialogue, foster collaboration, and provide attendees with actionable insights to enhance patient care and drive excellence in healthcare delivery.”

In his remarks, Dr. Ilankumaran Kaliamoorthy, Academic Committee, CAHOCON 2026 & CEO, Apollo Hospitals, Chennai, said: “CAHOCON 2026 brings together a distinguished lineup of speakers, including leading clinicians, researchers, and healthcare innovators. There will be 20 international speakers including Dr Eyal Zimlichman – Deputy Director General & Chief Quality Officer, Sheba Medical Center, Israel; ISQua Academy Member, and Prof David Bates – Chief, Division of General Medicine, Brigham and Women’s Hospital, USA, who will share their expertise and experiences. The event also attracts a diverse group of participants, from hospital administrators to frontline practitioners, creating a vibrant environment for learning, collaboration, and knowledge exchange. This convergence of minds ensures that every attendee gains fresh perspectives, practical insights, and the inspiration to implement best practices in their own institutions.”

CAHOCON 2026 has Dr. Nalla G Palaniswami, Chairman of Kovai Medical Centre and Hospital, as Org. Chairperson, and Dr. Gurushankar, Chairman of Meenakshi Mission Hospital and Research Centre, as one of the Org. Co-Chairpersons.

The press meet was attended also by Mr Adel J, FLAB Healthcare; Dr Arjun, New Medical Centre, Puducherry; Dr V.V. Jaichandran, Sankara Nethralaya; Ms Sandhya Cherian, Frontier Lifeline Hospital, Chennai; Dr Raju Sivasamy V P, SIMS Hospital, Dr Ashokan and Dr Babu Narayanan, GEM Hospital; Ms Gayathri Sandeep, Seethapathy Clinic; Dr Lasya Thambidurai, St. Peters Medical College; Dr Sudagar Singh, SRMC; Mr Venkat Phanidhar, Shasta Healthcare Solutions; Dr Jothi Clara, Healthbridge Company; Mr Mohammed Farouk, Rela Hospital, and Dr Balamurugan, Dr. Muthus Hospital.

SIMS Hospital Saves 65-Year-Old Scholar Requiring Over 250 shocks


SIMS Hospital Saves 65-Year-Old Scholar Requiring Over 250 shocks with Advanced Electrophysiological Intervention After Repeat Bypass Surgery

Chennai, March 11, 2026: SIMS Hospital saved the life of a 65-year-old religious scholar who developed a life-threatening ventricular tachycardia (VT) storm following a complex redo coronary artery bypass grafting. The patient required over 250 electric shocks over five days to control the dangerous heart rhythm before doctors finally stabilised him with a complex ablation procedure performed from both inside and outside the heart. To prevent future heart rhythm disturbances, doctors later implanted an Automated Implantable Cardioverter-Defibrillator, a device that can automatically detect and terminate dangerous heart rhythms.

The patient had previously undergone coronary artery bypass grafting in 2012 at another hospital. In recent months, he developed persistent chest pain and breathlessness. Investigations including coronary angiography revealed that multiple coronary arteries were critically blocked and the earlier bypass grafts had also failed. Echocardiography showed that the patient’s heart pumping function had dropped to around 27%, and doctors also identified a scarred, calcified bulge in the lower part of the heart.

Considering the failure of the earlier bypass grafts and the severely reduced blood supply to the heart, the surgical team, headed by Dr. V. V. Bashi, Director and Head of SIMS Institute of Cardiac & Aortic Disorders, performed a high-risk redo Coronary Artery Bypass Grafting (CABG) surgery to create new pathways for blood to flow to the heart by bypassing blocked coronary arteries.

However, about 24 hours after the surgery, the patient developed recurrent episodes of ventricular tachycardia, a dangerously rapid rhythm originating from the lower chambers of the heart. The abnormal heart rhythm was extremely dangerous and did not respond to standard treatments, including medications and specialised nerve-blocking procedures used to control severe rhythm disturbances. To restore normal rhythm and prevent cardiac arrest, the patient required repeated direct-current (DC) cardioversion shocks.

Although ventricular arrhythmias occurring shortly after bypass surgery usually resolve within 48 hours as heart function stabilises, the patient continued to experience incessant VT beyond five days. This condition, known as VT storm, required about 50 defibrillator shocks per day, amounting to nearly 250 shocks overall. Continuous monitoring was maintained in the intensive care unit, where a cardiologist and nursing staff remained at the patient’s bedside to deliver immediate shocks whenever the arrhythmia occurred.

Subsequently, an electrophysiology team led by Dr. Sanjai P. V, Clinical Lead – Cardiac Electrophysiology and Advanced Cardiac Pacing, conducted advanced electro-physiological evaluation and proceeded with emergency ventricular tachycardia ablation, a procedure to identify and treat abnormal electrical circuits responsible for the rhythm crisis. Initially, doctors performed the ablation procedure from inside the main pumping chamber of the heart to eliminate the abnormal electrical signals arising from scarred areas. However, some of the faulty signals were coming from the outer surface of the heart. Reaching this area was challenging because previous heart surgeries had caused the heart to stick closely to the surrounding tissues. To overcome this, doctors used a minimally invasive hybrid approach, creating a limited “keyhole” incision to deliver radiofrequency energy on the outer surface of the heart and eliminate the remaining arrhythmogenic circuits.

Following successful ablation, the patient remained in the hospital for nearly a month, including 15 days in the intensive care unit. He remained free from further VT episodes and was discharged in stable condition. One month after the procedure, the patient returned to the outpatient department and underwent implantation of an Automated Implantable Cardioverter-Defibrillator (AICD) to protect him from future malignant arrhythmias. This small device continuously monitors the heart rhythm and automatically delivers an internal shock if a dangerous rhythm recurs, thereby preventing sudden cardiac death. Currently, the patient is doing well.

In his comments, Dr. Bashi said that redo CABG itself is a complex surgical undertaking, particularly in patients with prior bypass surgeries and severely impaired heart function. However, given the patient’s progressive graft failure and severely reduced pumping capacity, surgery was the only definitive treatment option. “In my experience of nearly 45 years, this is the first time I have seen a patient requiring such a large number of defibrillator shocks continuously over five days and still recovering successfully,” he added.

Dr. Sanjai commented that the patient developed a rare and life-threatening VT storm following surgery. The arrhythmia originated from scarred regions within the left ventricle, including a heavily calcified area. Using advanced 3D mapping, we were able to identify the abnormal circuits and eliminate them through a combined endocardial-epicardial ablation approach.

Dr. Mohan’s Diabetes Specialities Centre Launches Genomic Lifestyle Counselling (GLC) – Marking a New Era in Precision Medicine

Chennai, March 7, 2026: Dr. Mohan’s Diabetes Specialities Centre, one of Asia’s largest and most respected diabetes care networks today announced the launch of its Genomic Lifestyle Counselling (GLC) program, a pioneering initiative designed to integrate genetic insights with personalized lifestyle interventions for the prevention and management of metabolic diseases.

Speaking at the launch, Dr. V. Mohan, Chairman emphasized that healthcare is rapidly transitioning from a generalized approach to precision-based care. He stated that genomic science now enables clinicians to understand individual susceptibility to conditions such as Type 2 diabetes, obesity, and cardiovascular disease. By leveraging genetic profiling, interventions can be tailored with greater accuracy, improving outcomes and long-term disease prevention.

Dr. Mohan highlighted that India faces a significant and growing burden of diabetes and obesity. Innovative strategies like Genomic Lifestyle Counselling represent a critical step towards predictive, preventive and personalized healthcare.

Dr. R. M. Anjana, Managing Director elaborated on the scientific framework of the GLC program. She explained that the model combines genomic risk assessment with structured lifestyle modification plans, including diet optimization, physical activity recommendations, and behavioural guidance. The goal is to provide patients with actionable, evidence-based strategies aligned with their genetic predispositions.

Dr. Anjana noted that this approach strengthens early risk identification and empowers individuals to make informed decisions to delay or prevent the onset of metabolic disorders.

Dr. Geeta Dharmatti, Nutrigenomic Counsellor detailed the practical implementation of GLC. She explained how nutrigenomics enables customized dietary planning based on gene–nutrient interactions, ensuring that nutrition advice is scientifically aligned with an individual’s metabolic profile. The program also integrates continuous counselling support to enhance adherence and measurable health outcomes.

The launch of Genomic Lifestyle Counselling reinforces Dr. Mohan’s Diabetes Specialities Centre’s commitment for over 35 years to research-driven innovation and comprehensive diabetes care. By embedding precision medicine principles into routine clinical practice, the institution aims to redefine preventive healthcare standards in India.

For more details, call 8939110000 or visit www.drmohans.com

Kauvery Group Launches Dedicated GI Bleed Centres Across Tamil Nadu

Chennai, March 2, 2026: Kauvery Group of Hospitals has launched dedicated GI Bleed Centres across all its hospitals in Tamil Nadu to provide timely evaluation, coordinated care, and comprehensive management of Gastrointestinal (GI) bleeding, a common medical emergency marked by internal bleeding within the digestive tract.

These centres will also be operational in the group’s hospitals in Karnataka. With 12 units across the two states, the initiative ensures patients have access to specialised, multidisciplinary care closer to home.

These centres bring together emergency physicians, gastroenterologists, intensivists, interventional radiologists, and surgeons under a coordinated care model. From arrival in the emergency department through risk assessment, ICU or ward admission, endoscopic or radiological intervention, and structured discharge planning, patients are managed along a clearly defined clinical pathway.

The centres are equipped with 24/7 emergency endoscopy services and advanced therapeutic endoscopic techniques, including injection therapy, band ligation, glue therapy, and coil embolisation. Interventional radiology support for angiographic embolisation, along with surgical expertise for complex cases, is available whenever required.

Speaking at the launch, Dr. P. Basumani, Director, Kauvery Institute of Digestive Sciences, said: “GI bleeding can result from ulcers, gastric erosions, or variceal bleeds linked to liver disease. Effective management depends on early assessment, stabilisation, accurate diagnosis, and timely intervention, as delays can be life-threatening. It requires a systematic, well-coordinated approach. At the Kauvery GI Bleed Centre, we have streamlined evidence-based protocols to ensure timely care at every stage. What truly makes a difference is teamwork – with multiple departments working seamlessly to deliver coordinated, patient-centred care.”

Highlighting the vision behind the initiative, Dr. Aravindan Selvaraj, Co-Founder and Executive Director of Kauvery Group of Hospitals, said: “Access to timely, specialised care is critical in managing medical emergencies. With Kauvery Hospitals across Tamil Nadu and Karnataka, we are bringing advanced GI bleed management closer to the communities we serve. Our goal is to standardise protocols across all units to ensure consistent quality, safety, and patient outcomes, regardless of location. This initiative underscores our ongoing commitment to strengthening emergency and critical care services.”

MGM Healthcare Launches ‘Swayam’, Chennai’s First Comprehensive Geriatric Program with a Dedicated Helpline Support for Seniors

Chennai, February 26, 2026: Setting a new benchmark in geriatric healthcare, MGM Healthcare has launched Swayam, Chennai’s first comprehensive, multidisciplinary geriatric programme built on a structured continuity-of-care model with a strong focus on restoring and sustaining quality of life. The programme is supported by a dedicated senior helpline (044-42004222) to assist elderly patients and their families.

The programme integrates outpatient services, dedicated in-patient wards including senior-friendly ICUs, and hospital-to-home care through direct visits, remote monitoring, and follow-up services for patients at home or in assisted-living facilities.

The programme was inaugurated by Col. K. Prabhakar Hebbar (Retd.), Mrs. Joseph Marita, Branch Head and Mrs. Kirshnaveni, Deputy Manager, Dignity Foundation and in the presence of Dr. Senathi Nanda Kishore, Clinical Director & Senior Consultant & Clinical Lead – Anaesthesiology and Surgical ICU, MGM Healthcare, and Dr. P. Sivaraj, Senior Consultant, Department of Internal Medicine, who heads Swayam.

Swayam distinguishes itself from conventional geriatric care by offering structured, assessment-driven services that integrate medical, psychological, functional, nutritional, sensory, dental, and home-based monitoring within one coordinated framework — ensuring clinical cohesion across specialties.

The team has expertise in comprehensive geriatric assessment; chronic disease management including diabetes, hypertension, and cardiovascular risk; polypharmacy review and medication rationalisation; preventive health and risk stratification; memory and cognitive evaluation; rehabilitation support; metabolic and renal disorder management; infection care; functional and mobility assessment; and frailty and fall-risk evaluation.

In his comments, Dr. Senathi Nanda Kishore said, “India is ageing rapidly, yet structured geriatric medicine remains underdeveloped. Ageing is often normalised as decline – chronic pain, loneliness, reduced mobility, polypharmacy, and sensory deterioration are accepted as ‘natural’. Swayam challenges this narrative. We are not merely a treatment clinic; we represent a proactive, preventive, and restorative ecosystem for senior wellbeing. We are not managing old age – we are optimising healthy ageing.”

Dr. Sivaraj said, “Current geriatric care is often fragmented across specialties – reactive rather than preventive, with limited psychological and social assessment. Medication management is seldom well integrated, and follow-up rarely extends into structured home-based care. In contrast, we offer Chennai’s most structured multidisciplinary geriatric programme, built on a true continuity-of-care model spanning outpatient, inpatient, and home care. The emphasis is on longitudinal monitoring rather than episodic intervention – reframing ageing from inevitable decline to a manageable, optimisable transition”.

Swayam follows an appointment-based model, limiting consultations to just five patients per day to ensure comprehensive, unhurried evaluations. Each visit offers multidisciplinary screening under one roof, including psychological assessments for loneliness and depression. The Hospital-to-Home continuity comprises quarterly Mobile Health Services, where a doctor, nurse, and physiotherapist visit patients’ homes for structured monitoring and ongoing care.

Rela Hospital Performs India’s First Wrist-Based Procedure to Treat Rare Bulge in Brain’s Blood Vessel with Intrasaccular Device

Chennai, February 2, 2026: Rela Hospital has successfully performed India’s first right transradial WEB embolisation, a minimally invasive procedure to treat a brain aneurysm, a bulge in the brain’s blood vessel, using an advanced implant delivered through an artery in the wrist. The procedure saved the life of a 60-year-old woman who had a rare and complex wide-neck aneurysm, a bulge with a wide opening. The innovative use of the WEB device also eliminated the need for stents or dual antiplatelet medications.

The advanced implant, known as Woven EndoBridge (WEB), is unique, as it is placed inside the aneurysm to block blood flow, preventing further bulging, rupture, or re-bleeding. Once sealed off, the aneurysm clots, shrinks, and becomes inactive. In this case, the WEB implant was delivered through the bloodstream to the affected brain vessel via the right wrist rather than the groin, using a guiding catheter and microcatheter.

The patient, a homemaker from Chennai, was rushed to the hospital after experiencing a sudden, severe headache followed by loss of consciousness, along with extremely high blood pressure measuring 230/140 mmHg. Her headache was intense and uncontrollable, and she remained unconscious on arrival.

An emergency CT brain scan followed by cerebral digital subtraction angiography (DSA) revealed bleeding in the space around the brain on the right side. Doctors identified a complex wide-neck aneurysm, where the balloon-like opening is broad, located at a bifurcation point, where one blood vessel splits into two. Given the high risk, the medical team promptly performed the emergency embolisation procedure.

The procedure was led by Dr. Muralidharan Vetrivel, Cerebrovascular Neurosurgeon and Neurointerventionist, with support from Senior Neurosurgeon Dr. Natesan Damodaran and Clinical Lead in Neuroanesthesia Dr. Ramanan Rajagopal.

In his comments, Prof. Mohamed Rela, Chairman, Rela Hospital, said, “This is the first time in India that a WEB device has been deployed inside a ruptured cerebral aneurysm through a transradial approach, marking a significant milestone in neurointerventional care. Treating wide-neck and bifurcation aneurysms is particularly complex, as these are rare, high-risk conditions that demand precision and speed. This breakthrough allows us to manage life-threatening aneurysms without opening the skull. By accessing the brain through a small puncture in the wrist, we not only minimise surgical trauma but also spare patients the prolonged bed rest and immobilisation associated with femoral artery access.”

In his comments, Dr. Muralidharan Vetrivel, said that “This procedure allows us to treat a life-threatening aneurysm without opening the skull, using only a small puncture in the wrist. We used specially designed catheters suitable for radial artery access and the WEB, a single intrasaccular device specifically designed for wide-neck aneurysms. Advanced support catheters, including the RIST system from Medtronic, were used to safely access the brain vessels through the radial route.”

The patient is recovering well and has been shifted out of the ICU. In cases of ruptured aneurysms, it typically takes around three weeks for subarachnoid haemorrhage and associated vasospasm (sudden narrowing or tightening of blood vessels) to subside. She is expected to remain hospitalised for 14–21 days and will require strict blood pressure control and optimisation of medications.

Dr. Muralidharan Vetrivel said that in India, the annual incidence of intracranial aneurysms ranges from 6 to 16 per 100,000 population, translating to an estimated 76,500 to 204,100 new cases each year. Prevalence reported in studies varies widely – from 0.75% to 10.3% – depending on the population studied and diagnostic methods used.

Hypertension is the primary risk factor, as it damages artery walls over time. Other major risk factors include smoking, excessive alcohol consumption, and the use of stimulant drugs such as cocaine and amphetamines. Genetic predisposition and a family history of aneurysms significantly increase risk. The condition is more common in women, especially after menopause, and typically occurs after the age of 40. Additional contributing factors include atherosclerosis, head injuries, blood infections, and certain congenital abnormalities.

To reduce risk, regular blood pressure monitoring and optimisation of medications, along with avoiding smoking and excessive alcohol intake, are required. People should seek immediate medical attention and undergo brain imaging such as CT or MRI if they experience a sudden onset of severe or unbearable headache – often described as the ‘worst headache of life’ – especially if accompanied by neck pain or loss of consciousness.